| Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine IM Al-masri, MK Mohammad, MO Tahaa Journal of enzyme inhibition and medicinal chemistry 24 (5), 1061-1066, 2009 | 225 | 2009 |
| Inhibition of hormone sensitive lipase and pancreatic lipase by Rosmarinus officinalis extract and selected phenolic constituents Y Bustanji, A Issa, M Mohammad, M Hudaib, K Tawah, H Alkhatib, ... J Med Plants Res 4 (21), 2235-42, 2010 | 153 | 2010 |
| Pancreatic lipase inhibition activity of trilactone terpenes of Ginkgo biloba Y Bustanji, IM Al-Masri, M Mohammad, M Hudaib, K Tawaha, H Tarazi, ... Journal of Enzyme Inhibition and Medicinal Chemistry 26 (4), 453-459, 2011 | 136 | 2011 |
| Pharmacophore modeling, quantitative structure–activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3β inhibitory activities for … MO Taha, Y Bustanji, MAS Al-Ghussein, M Mohammad, H Zalloum, ... Journal of medicinal chemistry 51 (7), 2062-2077, 2008 | 120 | 2008 |
| Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation Y Bustanji, MO Taha, IM Almasri, MAS Al-Ghussein, MK Mohammad, ... Journal of enzyme inhibition and medicinal chemistry 24 (3), 771-778, 2009 | 112 | 2009 |
| Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening MO Taha, Y Bustanji, AG Al-Bakri, AM Yousef, WA Zalloum, IM Al-Masri, ... Journal of Molecular Graphics and Modelling 25 (6), 870-884, 2007 | 106 | 2007 |
| Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening IM Al‐masri, MK Mohammad, MO Taha ChemMedChem: Chemistry Enabling Drug Discovery 3 (11), 1763-1779, 2008 | 79 | 2008 |
| Eugenol reduces LDL cholesterol and hepatic steatosis in hypercholesterolemic rats by modulating TRPV1 receptor AA Harb, YK Bustanji, IM Almasri, SS Abdalla Scientific Reports 9 (1), 14003, 2019 | 74 | 2019 |
| Screening of some medicinal plants for their pancreatic lipase inhibitory potential Y Bustanji, M Mohammad, M Hudaib, K Tawaha, IM Al-Masri, HS AlKhatib, ... Jordan Journal of Pharmaceutical Sciences 4 (2), 81-88, 2011 | 70 | 2011 |
| In vitro xanthine oxidase inhibition by selected Jordanian medicinal plants Y Bustanji, M Hudaib, K Tawaha, M Mohammad, I Almasri, S Hamed, ... Jordan Journal of Pharmaceutical Sciences 4 (1), 49-56, 2011 | 58 | 2011 |
| Inhibition of pancreatic lipase by berberine and dihydroberberine: an investigation by docking simulation and experimental validation M Mohammad, IM Al-masri, A Issa, A Khdair, Y Bustanji Medicinal Chemistry Research 22, 2273-2278, 2013 | 50 | 2013 |
| Olanzapine inhibits glycogen synthase kinase-3β: An investigation by docking simulation and experimental validation MK Mohammad, IM Al-Masri, MO Taha, MAS Al-Ghussein, HS AlKhatib, ... European journal of pharmacology 584 (1), 185-191, 2008 | 49 | 2008 |
| Antioxidant, antihyperuricemic and xanthine oxidase inhibitory activities of Hyoscyamus reticulatus MK Mohammad, IM Almasri, K Tawaha, A Issa, A Al-Nadaf, M Hudaib, ... Pharmaceutical biology 48 (12), 1376-1383, 2010 | 44 | 2010 |
| Antihyperuricemic and xanthine oxidase inhibitory activities of Tribulus arabicus and its isolated compound, ursolic acid: in vitro and in vivo investigation and docking … YB Eman Abu-Gharbieh, Naglaa G. Shehab, Ihab M. Almasri PLOS One 13 (8), 2018 | 42 | 2018 |
| Plant Products and Their Inhibitory Activity Against Pancreatic Lipase HR Bajes, I Almasri, Y Bustanji Revista Brasileira de Farmacognosia 30, 321-330, 2020 | 34 | 2020 |
| Functionalized furo [3, 2-c] coumarins as anti-proliferative, anti-lipolytic, and anti-inflammatory compounds: Synthesis and molecular docking studies TA Fattah, A Saeed, YM Al-Hiari, V Kasabri, IM Almasri, S AlAlawi, ... Journal of Molecular Structure 1179, 390-400, 2019 | 33 | 2019 |
| In silico screening for non‐nucleoside HIV‐1 reverse transcriptase inhibitors using physicochemical filters and high‐throughput docking followed by in vitro evaluation Y Bustanji, IM Al‐Masri, A Qasem, AG Al‐Bakri, MO Taha Chemical biology & drug design 74 (3), 258-265, 2009 | 32 | 2009 |
| Antilipase and antiproliferative activities of novel fluoroquinolones and triazolofluoroquinolones S Arabiyat, V Kasabri, Y Al‐Hiari, YK Bustanji, R Albashiti, IM Almasri, ... Chemical Biology & Drug Design 90 (6), 1282-1294, 2017 | 27 | 2017 |
| Docking simulations and in vitro assay unveil potent inhibitory action of papaverine against protein tyrosine phosphatase 1B Y Bustanji, MO Taha, IM Al-Masri, MK Mohammad Biological and Pharmaceutical Bulletin 32 (4), 640-645, 2009 | 25 | 2009 |
| Fluoroquinolones: novel class of gastrointestinal dietary lipid digestion and absorption inhibitors. IMAM Yusuf M. Al-Hiari, Violet N. Kasabri, Ashok K. Shakya, Muhammad H ... Med Chem Res 23 (7), 3336-3346, 2014 | 23 | 2014 |
Yasser BustanjiProfessor of Biochemistry and Clinical Chemistry, University of SharjahVerified email at ju.edu.jo
